Author:
Raobela Oméga,Andriantsoanirina Valérie,Rajaonera David Gael,Rakotomanga Tovonahary Angelo,Rabearimanana Stéphane,Ralinoro Fanomezantsoa,Ménard Didier,Ratsimbasoa Arsène
Funder
The Global Fund to Fight AID, Tuberculosis and Malaria
The Global Fund to Fight AIDS Tuberculosis and Malaria
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Parasitology
Reference22 articles.
1. PNLP. Plan stratégique de lutte contre le paludisme à Madagascar, 2013–2017. Antananarivo; 2013.
2. Menard D, Ratsimbasoa A, Randrianarivelojosia M, Rabarijaona LP, Raharimalala L, Domarle O, et al. Assessment of the efficacy of antimalarial drugs recommended by the National Malaria Control Programme in Madagascar: up-dated baseline data from randomized and multi-site clinical trials. Malar J. 2008;7:55.
3. Andriantsoanirina V, Ratsimbasoa A, Bouchier C, Jahevitra M, Rabearimanana S, Radrianjafy R, et al. Plasmodium falciparum drug resistance in Madagascar: facing the spread of unusual pfdhfr and pfmdr-1 haplotypes and the decrease of dihydroartemisinin susceptibility. Antimicrob Agents Chemother. 2009;53:4588–97.
4. Ndiaye JL, Randrianarivelojosia M, Sagara I, Brasseur P, Ndiaye I, Faye B, et al. Randomized, multicentre assessment of the efficacy and safety of ASAQ—a fixed-dose artesunate–amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria. Malar J. 2009;8:125.
5. WHO. Methods for surveillance of antimalarial drug efficacy. Geneva: World Health Organization; 2009.
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献